Conference
Low dose cytarabine may prevent hematologic relapse prior to hsct in patients with AML in first complete remission with minimal residual disease
Authors
Lindner S; Lang F; Pfeifer H; Berg T; Ajib S; Riemann J; Jedlickova Z; Gueller S; Toenges R; Steinmann J
Volume
54
Pagination
pp. 155-156
Publisher
NATURE PUBLISHING GROUP
Publication Date
July 1, 2019
Name of conference
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)
Conference place
Frankfurt, GERMANY
Conference start date
March 24, 2019
Conference end date
March 27, 2019
Conference proceedings
BONE MARROW TRANSPLANTATION
ISSN
0268-3369